Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV844
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 28, 2026, for the supply of SKYRIZI 360 mg/2.4 ml on-body injector sets. The contract, which represents a non-competitive delivery order, will be fulfilled from the prime contractor's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of February 19, 2026. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp functions as a critical vendor in the federal medical procurement supply chain, consistently delivering pharmaceuticals and medical supplies across multiple therapeutic domains to military treatment facilities and veteran healthcare systems. The parent company, Cencora, Inc., also holds a substantial IDC with DLA Troop Support Medical through December 2031, further demonstrating the organization's significant role in supporting Department of Defense pharmaceutical procurement operations. This specific delivery order for SKYRIZI, a dermatological therapeutic agent, exemplifies the company's capability to fulfill specialized pharmaceutical requirements within established federal contract frameworks.
Quick answers
Who was awarded contract SPE2DR26FV844?
SPE2DR26FV844 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FV844 worth?
The government has obligated $12,467 on SPE2DR26FV844.
Is contract SPE2DR26FV844 an order under another contract?
Yes. SPE2DR26FV844 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV844 competed?
The extent of competition for SPE2DR26FV844 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award